Mineralocorticoid Receptor Pathway and Its Antagonism in a Model of Diabetic Retinopathy

Volume: 70, Issue: 11, Pages: 2668 - 2682
Published: Aug 23, 2021
Abstract
Diabetic retinopathy remains a major cause of vision loss worldwide. Mineralocorticoid receptor (MR) pathway activation contributes to diabetic nephropathy, but its role in retinopathy is unknown. In this study, we show that MR is overexpressed in the retina of type 2 diabetic Goto-Kakizaki (GK) rats and humans and that cortisol is the MR ligand in human eyes. Lipocalin 2 and galectin 3, two biomarkers of diabetes complications regulated by MR,...
Paper Details
Title
Mineralocorticoid Receptor Pathway and Its Antagonism in a Model of Diabetic Retinopathy
Published Date
Aug 23, 2021
Journal
Volume
70
Issue
11
Pages
2668 - 2682
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.